U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07582783) titled 'A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania' on May 06.
Brief Summary: This study aims to assess the proportion of participants with moderate-to-severe plaque psoriasis who continue treatment with guselkumab over a two-year period.
Study Start Date: April 27
Study Type: OBSERVATIONAL
Condition:
Psoriasis
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Janssen Research & Development, LLC
Published by HT Digital Content Services with permission from Health Daily Digest....